Saskatchewan is launching a program to test the genomes of cancer patients who may face life-threatening side-effects from some chemotherapy drugs.
The test identifies genetic variants on a gene that affects the production of a certain enzyme.
The email you need for the day’s
top news stories from Canada and around the world.
Get daily National news
Get the day’s top news, political, economic, and current affairs headlines, delivered to your inbox once a day.
By providing your email address, you have read and agree to Global News’ Terms and Conditions and Privacy Policy.
Previously these tests were done in the U-S with a two-week turnaround time, but they would only take two to seven days once they can be done at the Royal University Hospital in Saskatoon.
The lab expects to test around one thousand patients a year.